Yes—CO-50 denials are eroding dermatology revenue by $180,000–$420,000 per 12 months when payers reject claims stating “these are non-covered services” for procedures you perform daily, creating systematic revenue loss from biologic administrations coded incorrectly, lesion destruction sessions exceeding visit limits, and cosmetic-versus-medical documentation failures triggering automatic claim rejections. A CO-50 denial code means “payer determined […]
Are CO-50 Denials Eroding Your Dermatology Revenue?









